Drug discovery startup Elucidata raises $5 Mn to fuel post-covid demand


Content Team
Image Credit: shortpedia

Delhi-based biomedical molecular data company Elucidata has raised $5 Mn in a pre-Series A funding round led by IvyCap Ventures. The round also saw participation from Hyperplane Venture Capital and a few angel investors. The company says that the funds will be utilised to accelerate product development, expand US operations, bolster marketing efforts and hire biotechnology and other talent in India.